The 80th Annual Meeting of the Japanese Society of Hematology

Session information

Morning Seminar

MS3-9

Immunotherapy of multiple myeloma~Long-term follow-up data Positioning of Elotuzumab~

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.9 (Osaka International Convention Center, 10F 1008)

Chair: Masahiro Kizaki (Department of Hematology, Saitama Medical Center, Saitama Medical University)

Sponsor: Bristol-Myers Squibb K.K.